 |
|
Comparative Ocular Pressure Elevation by Medrysone, Fluorometholone, and Dexamethasone Phosphate
Joel S. Mindel, MD, PhD;
Henry O. Tavitian, MD;
Harry Smith, Jr, PhD;
Ethel C. Walker, LPN
Arch Ophthalmol. 1980;98(9):1577-1578.
Abstract
• In age-, race-, and sex-matched groups, the relative abilities of medrysone, fluorometholone, and dexamethasone phosphate to elevate intraocular pressure were compared in a masked manner. Compliance was controlled by drops being given by nursing personnel. The 18 male hospitalized volunteers received commercial preparations of one of the corticosteroids to each eye four times a day for six weeks. The relative ability of medrysone, fluorometholone, and dexamethasone phosphate to raise IOP was 1, 4, and 7.6, respectively.
Author Affiliations
From the Ophthalmology Section (Dr Mindel and Ms Walker) and Psychiatry Department (Dr Tavitian) Bronx Veterans Hospital; and Departments of Ophthalmology, Pharmacology (Dr Mindel), and Biostatistics (Dr Smith), The Mount Sinai School of Medicine, New York.
Footnotes
Accepted for publication Feb 6, 1980.
Reprint requests to Annenberg Bldg 22-14, The Mount Sinai School of Medicine, 1 Gustave Levy P1, New York, NY 10029 (Dr Mindel).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Pharmacological Validation of a Feline Model of Steroid-Induced Ocular Hypertension
Bhattacherjee et al.
Arch Ophthalmol 1999;117:361-364.
ABSTRACT
| FULL TEXT
Intraocular Pressure-Raising Potential of 1.0% Rimexolone in Patients Responding to Corticosteroids
Leibowitz et al.
Arch Ophthalmol 1996;114:933-937.
ABSTRACT
Comparative Anti-inflammatory Efficacy of Topical Corticosteroids With Low Glaucoma-Inducing Potential
Leibowitz et al.
Arch Ophthalmol 1992;110:118-120.
ABSTRACT
|
